Drugs that contain Beclomethasone Dipropionate

1. Drug name - QNASL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7780038 TEVA BRANDED PHARM Dispensing apparatus with dosage counter Jan, 2027

(4 years from now)

US10188811 TEVA BRANDED PHARM Nasal spray device Oct, 2031

(9 years from now)

Treatment: NA

Dosage: AEROSOL, METERED;NASAL

More Information on Dosage
Strength Dosage Availability
0.04MG/ACTUATION AEROSOL, METERED;NASAL Prescription
0.08MG/ACTUATION AEROSOL, METERED;NASAL Prescription

2. Drug name - QVAR 40

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10086156 TEVA BRANDED PHARM Dose counter for inhaler and method for counting doses May, 2031

(8 years from now)

US10695512 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator May, 2031

(8 years from now)

US10022510 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof May, 2031

(8 years from now)

US10022509 TEVA BRANDED PHARM Dose counter for inhaler having a bore and shaft arrangement May, 2031

(8 years from now)

US9463289 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof May, 2031

(8 years from now)

US9808587 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator May, 2031

(8 years from now)

US10561808 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator Jan, 2032

(9 years from now)

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage
Strength Dosage Availability
0.04MG/INH AEROSOL, METERED;INHALATION Discontinued
0.08MG/INH AEROSOL, METERED;INHALATION Discontinued

3. Drug name - QVAR REDIHALER

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8132712 NORTON WATERFORD Metered-dose inhaler Sep, 2028

(5 years from now)

US10695512 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator May, 2031

(8 years from now)

US10022510 NORTON WATERFORD Dose counters for inhalers, inhalers and methods of assembly thereof May, 2031

(8 years from now)

US10086156 NORTON WATERFORD Dose counter for inhaler and method for counting doses May, 2031

(8 years from now)

US10022509 NORTON WATERFORD Dose counter for inhaler having a bore and shaft arrangement May, 2031

(8 years from now)

US8931476 NORTON WATERFORD Inhaler Jul, 2031

(8 years from now)

US10561808 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator Jan, 2032

(9 years from now)

US10792447 NORTON WATERFORD Breath actuated inhaler Jan, 2039

(16 years from now)

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage
Strength Dosage Availability
0.04MG/INH AEROSOL, METERED;INHALATION Prescription
0.08MG/INH AEROSOL, METERED;INHALATION Prescription

availability in other generic markets.

Click on the highlighted region to filter.